DealFlow OS
Get started free
Deal Structure Guide · IV Therapy Clinic

How to Structure an IV Therapy Clinic Acquisition

From SBA-backed asset purchases to equity rollovers for rollup platforms — a deal structure guide built specifically for the cash-pay IV hydration market.

Acquiring an IV therapy clinic requires deal structures that address three realities unique to this industry: the business operates at the intersection of healthcare regulation and lifestyle discretionary spending, revenue transferability depends heavily on retaining a medical director and a loyal membership base, and the financing landscape is constrained by SBA lender caution around healthcare-adjacent businesses. Most lower middle market IV therapy clinic transactions in the $1M–$5M revenue range close as asset purchases financed with a combination of SBA 7(a) debt, a seller note, and in some cases a performance-based earnout tied to post-close membership retention. Rollup platforms acquiring a second or third location may substitute an equity rollover for the earnout to align the seller's incentives with platform growth. Regardless of structure, deal terms in this space are consistently shaped by two negotiating levers: how dependent the business is on the outgoing owner as medical director or primary clinician, and how credibly recurring the revenue stream is through an active membership program.

Find IV Therapy Clinic Businesses For Sale

Full Asset Purchase with Seller Earnout

The buyer acquires all clinic assets — equipment, client database, brand, lease, clinical protocols, and contracts — while the seller receives a portion of the purchase price contingent on post-close performance. The earnout is typically tied to 12-month revenue retention or active membership count, protecting the buyer against immediate client or physician attrition after the ownership change.

10–20% of purchase price contingent, paid over 12 months post-close

Pros

  • Limits buyer downside if the medical director departs or membership churn accelerates post-close
  • Keeps the seller financially motivated to execute a clean transition and retain key staff and clients during the handover period
  • Clean asset transfer avoids assumption of undisclosed liabilities, including prior regulatory violations or unresolved malpractice claims

Cons

  • Sellers often resist earnouts, especially if they view the business as already de-risked through an established membership program
  • Earnout disputes are common when revenue metrics are not defined precisely — ambiguity around membership definitions or revenue recognition creates friction
  • Earnout periods can delay the seller's full liquidity event and complicate their ability to move on to other ventures

Best for: First-time buyers or SBA borrowers acquiring a single-location clinic where the outgoing owner served as the primary medical director or face of the business, and where membership retention post-close is genuinely uncertain.

SBA 7(a) Loan with Seller Note

The buyer finances 75–90% of the purchase price through an SBA 7(a) loan, with the seller carrying a subordinated promissory note covering the remainder. This is the most common structure for first-time buyers and individual operators acquiring IV therapy clinics in the $1M–$3M purchase price range. The seller note is typically subordinated to the SBA lender and structured with a standby period during which no payments are made.

SBA loan covers 75–90% of purchase price; seller note covers 10–25%

Pros

  • Maximizes buyer leverage with minimum equity injection — SBA typically requires 10–15% down for established businesses with 2+ years of history
  • Spreads seller proceeds over time, which can be advantageous for sellers from a capital gains tax deferral perspective
  • SBA lenders are increasingly familiar with cash-pay medical businesses and IV clinics with documented recurring revenue, improving deal fundability

Cons

  • SBA underwriting will scrutinize the medical director agreement transferability and may require a post-close employment or consulting agreement with the outgoing owner as a loan condition
  • Seller note standby provisions can leave the seller with no cash flow from the note for 24 months, which not all sellers will accept
  • SBA loan processing timelines of 60–90 days can introduce deal risk if the seller has competing buyers or a lease renewal deadline approaching

Best for: Individual buyers, nurse practitioners, or first-time healthcare entrepreneurs acquiring an established single-location IV clinic with at least $500K EBITDA and 2+ years of clean financials.

Equity Rollover with Minority Seller Stake

Rather than paying the seller out entirely at close, the buyer — typically a PE-backed rollup platform or multi-location operator — offers the seller a minority equity stake in the acquiring entity in addition to a cash payment at close. The seller rolls equity worth 10–20% of the transaction value into the platform, participating in future upside as the rollup scales and ultimately exits.

60–80% cash at close; 10–20% equity rollover in acquirer entity; optional 10% earnout

Pros

  • Aligns the seller's incentives with long-term platform performance, making them an active advocate for client and staff retention post-close
  • Reduces the cash required at close, allowing the rollup platform to deploy capital across more acquisitions simultaneously
  • Seller participation in a second bite of the apple can yield a higher total payout than a clean cash exit if the platform achieves a strong multiple at its own exit

Cons

  • Sellers unfamiliar with private equity structures may undervalue or distrust the equity component without clear visibility into platform financials and exit timelines
  • Minority equity stakes offer limited control, and if the platform underperforms or pivots strategy, the seller has little recourse
  • Valuation of the equity stake at close requires agreement on platform-level metrics that can be difficult to negotiate without sophisticated advisors on both sides

Best for: Multi-location operators or clinic founders with strong local brand equity who are being acquired by a wellness or med spa rollup platform and want ongoing exposure to the platform's upside.

Sample Deal Structures

Single-location IV clinic, $1.8M revenue, $550K EBITDA, owner is medical director with 18-month transition commitment

$2.4M (4.4x EBITDA)

SBA 7(a) loan: $1.92M (80%); Seller note: $240K (10%); Buyer equity injection: $240K (10%)

SBA loan at 10-year term, variable rate (WSJ Prime + 2.75%); Seller note subordinated, 24-month standby, then 36-month amortization at 6.5%; No earnout given owner's 18-month post-close consulting agreement securing medical director continuity; Seller consulting fee of $8K/month for 18 months included in operating budget

Two-location IV clinic with mobile unit, $3.2M revenue, $820K EBITDA, active membership program with 280 members, transferable medical director agreement

$3.7M (4.5x EBITDA)

SBA 7(a) loan: $2.775M (75%); Seller note: $370K (10%); Buyer equity: $555K (15%)

Earnout of $370K (10% of purchase price) paid over 12 months tied to maintaining 240+ active members at month 12 post-close; Seller note at 6% interest, 18-month standby, 48-month repayment; Medical director retained under a new independent contractor agreement at $4,500/month; Lease assignments for both locations completed at close with landlord consent obtained during due diligence

IV clinic being acquired by PE-backed med spa rollup, $2.6M revenue, $700K EBITDA, 3 years operating history, strong Google reputation, single location in high-income metro

$3.15M (4.5x EBITDA)

Cash at close: $2.52M (80%); Equity rollover into platform: $630K in platform units (20%)

No earnout — equity rollover replaces performance contingency; Seller joins platform as regional clinical director at $120K base salary for 24 months; Platform equity valued at $12M enterprise value at time of acquisition; Seller's 5.25% minority stake subject to 3-year lockup with drag-along rights; Seller note not required given PE sponsor's balance sheet capacity

Negotiation Tips for IV Therapy Clinic Deals

  • 1Push hard on medical director continuity before agreeing to any purchase price — if the outgoing owner is the medical director, require a written transition plan identifying a licensed replacement physician before LOI signature, and price a replacement physician's annual cost of $50K–$80K into your EBITDA normalization
  • 2Structure earnout metrics around active membership count rather than gross revenue to remove ambiguity — define 'active member' explicitly as a client who has made at least one purchase in the prior 60 days, and require the seller to provide monthly membership reports during the earnout period
  • 3Require the seller to obtain written landlord consent to lease assignment before entering exclusivity — IV clinic real estate is often in medical office or retail strip configurations with landlord approval clauses that can delay or kill deals if addressed too late
  • 4Negotiate a clinical protocol review period into your due diligence timeline — engage a healthcare compliance attorney to audit nurse scope-of-practice documentation, compounding pharmacy agreements, and state health department licensing at least 30 days before your financing contingency deadline
  • 5If using SBA financing, proactively prepare a lender package that includes the medical director agreement, a letter from the replacement physician confirming post-close participation, and 3 years of accrual-based financials — lenders will request these documents anyway and early submission accelerates underwriting
  • 6For rollup equity rollovers, insist on a clear definition of the platform's exit timeline and methodology for valuing the seller's minority stake at the platform's future exit — vague rollover terms without drag-along, tag-along, and put option provisions expose the seller to permanent illiquidity in a platform that never exits

Find IV Therapy Clinic Businesses For Sale

Pre-screened targets ready for your deal structure — free to join.

Get Deal Flow

Frequently Asked Questions

What is the typical purchase price multiple for an IV therapy clinic acquisition?

Most IV therapy clinic acquisitions in the lower middle market close between 3x and 5.5x EBITDA. Single-location clinics with owner-dependent revenue and limited membership programs tend to trade at the lower end of that range (3x–4x), while multi-location operators with 200+ active members, transferable medical director agreements, and documented NAD+ or weight loss service lines can command 4.5x–5.5x. Revenue multiples are less commonly used but typically fall between 0.8x and 1.5x annual revenue depending on margin profile.

Can I use an SBA 7(a) loan to buy an IV therapy clinic?

Yes, IV therapy clinics are generally SBA-eligible businesses, and 7(a) loans are the most common financing vehicle for individual buyers acquiring clinics in the $1M–$3M purchase price range. SBA lenders will scrutinize the medical director agreement structure, state licensing compliance, and the credibility of recurring revenue claims. Clinics with at least $500K EBITDA, 2+ years of operating history, and clean accrual-based financials prepared by a CPA are the most fundable. Expect 60–90 day underwriting timelines and plan to inject 10–15% equity at close.

How does an earnout work in an IV therapy clinic deal?

An earnout in an IV therapy clinic acquisition is a contingent payment — typically 10–20% of the purchase price — paid to the seller after close based on the business hitting defined performance milestones during a 12-month window. The most commonly used metrics are total revenue retention and active membership count. For example, a seller might receive $200K of a $2M purchase price only if the clinic maintains at least 85% of pre-close revenue in the 12 months following closing. Earnouts are most appropriate when the seller is the medical director or primary rainmaker, and less necessary when the clinic has strong membership infrastructure and a third-party physician agreement already in place.

What happens to the medical director agreement when a clinic is sold?

This is one of the most critical issues in any IV therapy clinic acquisition. Most medical director agreements are written as personal service contracts and are not automatically assignable to a new owner. During due diligence, buyers must review the existing agreement to determine whether it contains an assignment clause or requires the physician's consent. In many deals, the existing medical director is retained post-close under a new independent contractor agreement negotiated as part of the acquisition. If the seller is the medical director, the buyer must recruit and onboard a replacement physician — ideally before close — and SBA lenders may require a signed replacement physician agreement as a loan condition.

What are the most common deal killers in IV therapy clinic acquisitions?

The most frequent deal killers are: (1) discovery that the owner is the sole medical director with no succession plan and no replacement physician willing to sign on; (2) undocumented clinical protocols or missing patient intake records that create liability exposure a buyer cannot underwrite; (3) non-compliant compounding pharmacy relationships where the clinic is sourcing IV products from unregistered or out-of-state compounders; (4) lease assignments that require landlord consent the seller failed to obtain, stalling close; and (5) revenue that proves to be non-recurring upon deeper diligence — walk-in dominated models without membership infrastructure are heavily discounted or passed on by institutional buyers.

Should I buy the assets or the equity when acquiring an IV therapy clinic?

Almost universally, buyers in this space purchase assets rather than equity. An asset purchase allows the buyer to selectively assume only the contracts, licenses, and equipment they want while leaving behind undisclosed liabilities — prior malpractice claims, state board complaints, unpaid vendor invoices, or regulatory fines the seller may not have disclosed. In an equity purchase, the buyer inherits the legal entity and everything inside it, including hidden liabilities. The primary exception is when a rollup platform acquires a clinic and needs to preserve specific state healthcare licenses that are tied to the legal entity rather than the owner — in that case, equity purchases may be structured with heavy representations and warranties insurance to manage the liability risk.

More IV Therapy Clinic Guides

Acquire a IV Therapy Clinic Business →Valuation Guide →SBA Loan Guide →LOI Template →Due Diligence →

More Deal Structure Guides

Janitorial Supply Distributor →Juice Bar & Smoothie Shop →Junk Removal →Kitchen & Bath Remodeling →Kombucha & Functional Beverage →Lab & Diagnostics Company →Landscaping →Language School →Browse all deal structure guides →

Start Finding IV Therapy Clinic Deals Today — Free to Join

Find the right target, structure the deal, and close with confidence.

Create your free account

No credit card required

For Buyers

For Sellers

Free Tools

Platform

DealFlow OS
© 2026 DealFlow OSPrivacy PolicyTerms of Service